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1. Introduction
Several animal models of  experimental autoimmune myocardi-
tis (EAM) have been developed in various rodent species to study 
the immunological mechanisms of  myocardial injuries. Autoim-
mune myocarditis can be induced in susceptible animals by im-
munizing the animals with myocarditogenic epitopes of  cardiac 
myosin heavy chain (Myhc)-α; the disease is mediated primarily 
by CD4 T cells (Liao et al., 1993; Donermeyer et al., 1995). The 
disease-inducing epitopes of  Myhc-α have been characterized in 
mice and rats, notably Myhc-α 334–352 in A/J (H-2a), CBA/J 
(H-2k) and B10.A (H-2k) mice; Myhc-α 614–643 in BALB/c (H-
2d) mice; and Myhc-α 1304–1320 in Lewis rats (RT1) (Neu et 
al., 1987b; Kodama et al., 1990; Smith and Allen, 1991; Doner-
meyer et al., 1995; Pummerer et al., 1996). Myhc has two iso-
forms, Myhc-α and Myhc-β, which are expressed at different times 
during development. Myhc-α is expressed in adult mice, whereas 
Myhc-β is expressed in the fetus (Pummerer et al., 1996; Reiser 
et al., 2001; Hill et al., 2002), suggesting that the T cell repertoire 
of  the Myhc-α form may have escaped tolerance mechanisms in 
the thymus. The fact that myocarditis could be induced with only 
Myhc-α but not Myhc-β raises a question whether susceptible mice 
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Abstract
A/J mice bearing the H-2 allele IAk are highly susceptible to autoimmune myocarditis induced with cardiac my-
osin heavy chain (Myhc)-α 334–352, whereas B10.A mice carrying a similar allele IAk are relatively resistant, 
suggesting that the generation of  Myhc-α-reactive T cell repertoires is influenced by genetic background. To enu-
merate the precursor frequencies of  Myhc-α-specific CD4 T cells, we sought to create IAk tetramers for Myhc-α 
334–352. Tetramers were created using approaches that involve covalent tethering of  individual peptide sequences 
or exogenous loading of  peptides into empty IAk molecules by peptide-exchange reaction. Using ribonuclease 43–
56 tetramers as controls, we demonstrated that by flow cytometry (FC), Myhc-α 334–352 tetramers specifically 
bind myosin-reactive T cells. CD4 cells isolated from A/J mice immunized with Myhc-α 334–352 were used to 
optimize conditions for tetramer staining, and neuraminidase treatment prior to tetramer staining permitted the 
detection of  Myhc-α-specific cells ex vivo. The reagents are useful tools for monitoring the frequency of  Myhc-α-
reactive CD4 cells and to determine their pathogenic potential at a single cell level by FC.
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Abbreviations: DELFIA, dissociation-enhanced lanthanide fluoroimmunoassay; EAM, experimental autoim-
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heavy chain-α; NASE, neuraminidase; OE-PCR, overlapping extension polymerase chain reaction; Tet, tetramer
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have endogenously derived a Myhc-α-specific T cell repertoire, 
which expands upon immunization with myosin.
Our studies involve A/J mice carrying the H-2 allele IAk 
at the major histocompatibility complex (MHC) class II locus, 
which are highly susceptible to EAM induced with Myhc-α 334–
352 (Donermeyer et al., 1995). In contrast, B10.A mice, which 
also carry the IAk allele, are relatively resistant, suggesting that 
both MHC and non-MHC genes contribute to susceptibility to 
myocarditis (Neu et al., 1987b). To investigate these genetic dif-
ferences, we created IAk tetramers for Myhc-α 334–352. Using 
bovine ribonuclease (RNase) 43–56 tetramers as controls, we 
demonstrated that Myhc-α 334–352 tetramers bind myosin-re-
active cells with specificity, and the reagents are useful in de-
tecting antigen-specific cells ex vivo.
 
2. Materials and methods
2.1. Mice
We used 6- to 8-week-old female A/J mice (H-2a), obtained 
from the Jackson Laboratory (Bar Harbor, ME) and main-
tained in accordance with the guidelines of  the University of  
Nebraska-Lincoln.
2.2. Peptide synthesis and immunization procedures
Myhc-α 334–352 (DSAFDVLSFTAEEKAGVYK), and 
RNase (VNTFVHESLADVQA) were synthesized on 9-fluo-
renylmethyloxycarbonyl chemistry (Neopeptide, Cambridge, 
MA). All peptides were HPLC-purified (> 90%), identity was 
confirmed by mass spectroscopy, and the peptides were dis-
solved in 1× PBS prior to use. For immunizations, peptides were 
emulsified in complete Freund’s adjuvant (CFA) supplemented 
with Mycobacterium tuberculosis extract to a final concentration 
of  5 mg/ml, and administered subcutaneously in multiple sites 
in the flank, footpads and sternal regions (100 μg/mouse) ( Do-
nermeyer et al., 1995; Pummerer et al., 1996).
2.3. Creation of  IAk constructs and expression of  soluble IAk 
monomers
Full length cDNAs representing IAk-α and IAk-β chains were 
synthesized by RT-PCR using total RNA extracted from spleno-
cytes stimulated with lipopolysaccharide and interferon-γ. To ex-
press soluble IAk molecules, transmembrane and cytoplasmic re-
gions of  IAk-α and IAk-β chains were replaced with the leucine 
zipper domains of  Fos and Jun transcriptional factors, respectively, 
as described previously (Jang et al., 2003; Reddy et al., 2003). 
We adopted two approaches to create IAk tetramers (Figure 1).
2.3.1. Derivation of  tetramers using MHC class II-associated invari-
ant chain peptide (CLIP) precursors
This approach involved covalent tethering of  nt sequences of  
CLIP 88–102 (gtgagccagatgcggatggctactcccttgctgatgcgtccaatg) 
into the IAk-β construct such that upon expression, CLIP-linked 
IAk proteins were obtained and tetramers could then be de-
rived by exchanging CLIP with peptides of  interest (Day et al., 
2003; Jang et al., 2003).
IAk-α construct. First, we amplified the sequence of  ex-
tracellular (E/C) domain from full length IAk-α cDNA, in-
cluding the leader sequence, and the fragment was flanked 
by Bam H I (5′) and Sal I (3′) sites. Second, a fragment 
containing Fos and the BiR-A site for biotinylation was 
synthesized by overlapping extension PCR (OE-PCR) to 
include Sal I and Bam H I sites at 5′ and 3′ ends, respec-
tively. The two fragments were then ligated using Sal I 
and cloned into the Bam H I site in p10 dual promoter-
containing pAcDB3 vector (BD Pharmingen, San Diego, 
CA). The final IAk-α construct should then have con-
tained, in the order of  leader sequence: E/C domain, linker 
(GGGGG), Fos (LTDTLQAETDQLEDEKSALQTE-
IANLLKEKEKLEFILAA), linker (SAGGG) and BiR-
A site (GLNDIFEAQKIEWHE).
IAk-β construct. Generation of  the IAk-β construct re-
quired three cassettes. Cassette 1: PCR product was syn-
thesized by OE-PCR to include leader sequence, Kpn I 
site, CLIP 88–102 (VSQMRMATPLLMRPM), linker 
(GGGGS), thrombin cleavage site (LVPRGS), and Bam 
H I/linker (GSGSGS). Cassette 2: PCR product flanked 
by Bam H I (5′) and Sal I (3′) sites, generated from full-
length IAk-β cDNA to include E/C region of  IAk-β, was 
obtained. Cassette 3: PCR product flanked by Sal I (5′) and 
EcoR I (3′) sites representing the Jun sequence was ampli-
fied from IAs/myelin proteolipid protein (PLP) 139–151 
construct (a kind gift from Dr. Vijay Kuchroo, Harvard 
University, Boston, MA) ( Reddy et al., 2003). We ligated 
cassettes 2 and 3 first, followed by cassette 1, and the full-
length construct thus derived was cloned into Bgl II and 
EcoR I sites in pAcDB3 vector and sequenced.
2.3.2. Derivation of  tetramers using peptide-precursors
In this approach, nt sequences of  Myhc-α 334–352 and RNase 
43–56 were tethered into the IAk-β construct, which permitted 
Figure 1. Strategies adopted to create IAk tetramers. A, derivation of  tetra-
mers from CLIP precursors. This approach involved covalent tethering of  
the nt sequence of  CLIP 88–102 into the IAk-β construct, followed by ex-
pression of  soluble IAk molecules, biotinylation, thrombin cleavage, pep-
tide loading and tetramerization. B, derivation of  tetramers from peptide 
precursors. In this approach, the nt sequences of  Myhc-α 334–352 and 
RNase 43–56 were covalently tethered into the IAk-β construct such that 
IAk monomers containing the peptides were expressed directly. *Steps per-
taining to CLIP precursors only.
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expression of  peptide-linked monomers directly (Massilamany et 
al., 2010). We used the IAk-α construct designed to obtain CLIP 
precursors and modified the IAk-β construct by replacing the se-
quences of  CLIP and thrombin cleavage site with Myhc-α 334–352 
(gatagtgcctttgatgtgctgagcttcacggcagaggagaaggctggtgtctacaag) 
or RNase 43–56 (gtgaacacctttgtgcacgagtccctggctgatgtccaggcc).
The soluble IAk molecules were expressed in a Baculovirus 
system using sf9 insect cells as described previously (Reddy et 
al., 2003; Massilamany et al., 2010). Briefly, large-scale protein 
production was performed in suspension cultures grown in spin-
ner flasks attached to a sparger system (Bellco, Vineland, NJ) 
at a multiplicity of  infection 5. Cells were grown at a density 
of  1 × 106 cells/ml in protein-free insect cell medium (SF900 
III SFM, Invitrogen, Carlsbad, CA) for 3 to 5 days; the super-
natants were concentrated using a Prep/Scale-TFF cartridge 
(30 kDa) (Millipore, Bellerica, MA) and purified on anti-IAk 
column (clone, 10–2.16). The protein elutes were concentrated 
using Amicon ultra centrifugal filters (Millipore), and the pro-
tein yield typically ranged from 1 to 1.6 mg/l, regardless of  IAk 
constructs used.
2.4. Biotinylation, thrombin cleavage, peptide-exchange and 
tetramerization
Biotinylation of  IAk proteins was performed using biotin 
protein ligase (Avidity, Denver, CO) at 30 °C in a reaction mix-
ture containing 25 μg/10 nM of  enzyme and 2.5 mg/ml of  IAk 
proteins (Reddy et al., 2003). After overnight incubation, free 
biotin was removed by dialysis using ice-cold 1× PBS in multi-
ple cycles over a period of  24 h.
Thrombin digestion was carried out at room temperature (RT) 
for 2 h in 10 mM Tris HCl, pH 8.0, consisting of  biotinylated 
IAk proteins (1–2 mg/ml) and thrombin (20 units/mg) (Nova-
gen, Madison, WI; Day et al., 2003; Jang et al., 2003). Throm-
bin-cleaved IAk proteins were resolved in 12% sodium dodecyl 
sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE) anal-
ysis and the migration pattern of  the IAk-β chain was compared 
with uncleaved IAk protein.
To validate conditions for peptide-exchange reactions, we 
used dinitrophenol (DNP)-labeled Myhc-α 334–352 or RNase 
43–56 in which a DNP tag was attached with one aminohexa-
noic acid linker at the N-terminus. The peptide purity (> 92%) 
was verified by mass spectrometry and HPLC (Neopeptide; Day 
et al., 2003; Jang et al., 2003). The conditions used for optimi-
zation included temperature, concentration of  IAk proteins and 
peptides (molar ratios, 3.3 μM:16.5 μM to 3.3 μM:132 μM) and 
pH (5.5 to 7.5). Briefly, thrombin-cleaved, unbiotinylated IAk 
monomers and DNP-Myhc-α 334–352 were incubated in du-
plicates in a peptide-exchange buffer containing sodium phos-
phate 50 mM, sodium chloride 100 mM, EDTA 1 mM and 1× 
protease inhibitor overnight at RT. The reaction mixture was 
coated onto 96-well white fluorescence plates (Nunc, Roches-
ter, NY) in sodium phosphate 0.2 M, pH 6.8 overnight at 4 °C. 
The plates were washed 5 times with 1× wash buffer (Perkin 
Elmer, Waltham, MA) and blocked with casein 2% for 2 h at 
37 °C. After washing as above, biotinylated anti-DNP was added 
(0.25 μg) to each well (American Research Products, Belmont, 
MA) and incubated for 1 h at RT. Europium-labeled strepta-
vidin (SA) was then added to a concentration of  1 μg/ml of  
dissociation-enhanced lanthanide fluoroimmunoassay (DEL-
FIA) buffer followed by DELFIA-enhancement solution (Per-
kin Elmer; Jang et al., 2003). Fluorescence intensity was mea-
sured at excitation/emission wavelengths of  340/615 nm using 
a Victor3 Multi Label Plate Reader (Perkin Elmer). The opti-
mized conditions were then used to generate tetramers utiliz-
ing biotinylated thrombin-cleaved IAk proteins and unlabeled 
Myhc-α 334–352 or RNase 43–56.
2.5. Western blotting analysis
IAk-α and IAk-β chains contained the leucine zipper domains 
of  Fos and Jun, respectively (Reddy et al., 2003). The soluble 
IAk molecules in the Baculovirus-infected supernatants were 
resolved in 12% SDS-PAGE analysis and probed with rabbit 
anti-Fos and anti-Jun polyclonal sera (a kind gift from Dr. Vi-
jay Kuchroo) (Reddy et al., 2003). The Fos- and Jun-antibody 
complexes were captured by goat anti-rabbit secondary antibody 
conjugated with horseradish peroxidase, and the signals were 
detected by enhanced chemiluminescence (ECL).
2.6. Measurement of  recall responses
Ten days after immunization with Myhc-α 334–352 or RNase 
43–56, mice were killed and the draining lymph nodes (LN) 
(maxillary, mandibular, popliteal, axillary and inguinal) were 
harvested. Single cell suspensions were prepared after lysing 
the erythrocytes with 1× ammonium chloride potassium buffer 
(Lonza, Walkersville, MD). Lymph node cells (LNC) were stim-
ulated with the indicated peptides (0–100 μg/ml) at a cell den-
sity of  5 × 106 cells/ml for 2 days in growth medium contain-
ing 1× RPMI supplemented with 10% fetal calf  serum (FCS), 
1 mM sodium pyruvate, 4 mM l-glutamine, 1× each of  non-es-
sential amino acids and vitamin mixture, and 100 U/ml pen-
icillin–streptomycin (Lonza). Cultures were then pulsed with 
1 μCi of  tritiated 3[H] thymidine per well; 16 h later, prolifera-
tive responses were measured as counts per minute (cpm) using 
the Wallac liquid scintillation counter (Perkin Elmer; Reddy et 
al., 2003; Massilamany et al., 2010).
2.7. IAk tetramer staining
IAk/Myhc-α 334–352 and RNase 43–56 tetramer staining 
was performed by three- or four-color flow cytometry (FC) 
as we have previously described (Massilamany et al., 2010). 
LNC obtained from mice immunized with Myhc-α 334–352 
or RNase 43–56 were restimulated with the corresponding 
peptides (50 μg/ml), and after 2 days growth medium con-
taining interleukin (IL)-2 was supplemented. Viable lympho-
blasts were harvested on day 5 poststimulation by Ficoll-den-
sity gradient centrifugation and the cells were maintained in 
IL-2 medium. Tetramer staining was performed by incubating 
the cells with IAk/Myhc-α 334–352 or RNase 43–56 tetramers 
conjugated with phycoerythrin (PE) in growth medium, pH 7 
to 8.2, at 4 °C, 37 °C or RT for 0.5 to 3 h. Cells were washed 
twice with 5 ml of  1× PBS and incubated with anti-CD4, anti-
CD25 or anti-CD40 ligand (CD40L) (eBioscience, San Diego, 
CA), and 7-aminoactinomycin D (7-AAD; Invitrogen) on ice 
for 20 min. After washing as above, cells were acquired by a 
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flow cytometer (FACScan or FACSCalibur, BD Biosciences, 
San Diego, CA), and the frequency of  tetramer (tet)+ cells was 
then enumerated by using Flow Jo software (Tree Star, Ash-
land, OR) in the live (7-AAD−) population. Tetramer staining 
was optimized with respect to concentration of  tetramers, du-
ration, temperature, pH and the amount of  FCS in the staining 
medium. The reaction conditions for each of  the parameters 
were as follows: concentration of  tetramers, and temperature 
(RT for 3 h, FCS 2.5%, pH 7.6); duration (RT, FCS 2.5%, pH 
7.6); pH (RT for 3 h, FCS 2.5%) and amount of  FCS (RT for 
3 h, pH 7.6).
2.8. Effect of  neuraminidase (NASE) on IAk/tetramer staining
Myhc-α 334–352 reactive cell cultures were prepared from 
A/J mice as above and the cells were maintained in IL-2 me-
dium for 2 weeks. Cells were then treated with or without NASE 
(0.7 units/ml) (Type X from Clostridium perfringens, Sigma-Al-
drich, St. Louis, MO) in serum-free 1× DMEM for 45 min at 
37 °C at a density of  1 × 107 cells/ml ( Reddy et al., 2003). Af-
ter washing once with 5 ml of  1× PBS, cells were stained with 
tetramers, anti-CD4 and 7-AAD and acquired by FC. Tet+ cells 
were analyzed in the live (7-AAD−) CD4 subset.
2.9. Detection of  Myhc-α 334–352-reactive CD4 cells by IAk tet-
ramer staining ex vivo
A/J mice were immunized with Myhc-α 334–352 in CFA 
twice with an interval of  1 week. After 7 days, the mice were 
killed and LNC were prepared and used to determine the effect 
of  NASE on T cells. LNC were treated with or without NASE 
as above followed by staining with CD4, CD69, CD25, CD44 
and CD62 ligand (CD62L) antibodies and 7-AAD. After ac-
quiring the cells by FC, percentages of  each marker were de-
termined in the live (7-AAD−) CD4 subset. For tetramer anal-
ysis, LNC were obtained from a pool of  draining LN obtained 
from three to five mice in each experiment. CD4 cells were en-
riched to a purity of  more than 95% by negative selection based 
on magnetic separation using IMAG according to the manufac-
turer’s recommendations (BD Biosciences). After treating the 
cells with or without NASE as above, cells were incubated with 
tetramers (30 μg/ml) for 3 h at RT in growth medium, pH 7.6, 
supplemented with FCS (2.5%). Cells were washed twice with 
5 ml of  1× PBS and stained with anti-CD4, anti-CD25, and 
7-AAD and acquired by a flow cytometer (FACSCalibur, BD 
Biosciences). The live (7-AAD−) CD25+ cells were gated first 
in relation to forward scatter (FSC) and in which tet+ cells were 
determined corresponding to CD4 subset.
2.9.1. Enrichment of  tet+ cells by magnetic separation
Tetramer-positive cells were enriched using anti-PE magnetic 
particles as described previously (Day et al., 2003; Jang et al., 
2003). Briefly, A/J mice were immunized with Myhc-α 334–352 
in CFA twice with an interval of  1 week. Seven days after the 
second immunization, draining LN were pooled from groups 
of  three to five mice each and LNC were obtained. CD4 cells 
were enriched to a purity of  more than 95% (as described in Sec-
tion 2.9) and stained with PE-conjugated IAk tetramers (30 μg/
ml) for 3 h at RT in growth medium containing 2.5% FCS, pH 
7.6. Cells were washed with 1× BD IMag buffer and incubated 
with anti-PE magnetic particles for 30 min at 4 °C. The anti-
PE-bound tet-PE+ cells were then enriched using IMag as rec-
ommended (BD Biosciences). Cells were stained with anti-CD4 
and 7-AAD and acquired by a flow cytometer (FACSCalibur, 
BD Biosciences) and the percentages of  tet+CD4+ cells were 
then enumerated in the live (7-AAD−) subset using Flow Jo soft-
ware. To enrich tet+ cells from in vitro expanded cultures, viable 
lymphoblasts harvested on day 8 poststimulation with Myhc-α 
334–352 were used for magnetic separation as described above.
3. Results
3.1. Creation of  IAk tetramers
IAk tetramers were created utilizing CLIP or peptide precur-
sors (Figure 1). The IAk constructs corresponding to each ap-
proach were designed and successfully expressed in a Baculovi-
rus system (Figure 2). We confirmed the identity of  IAk-α and 
IAk-β chains by Western blotting analysis by testing anti-Fos 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Derivation of  IAk tetramers. A, IAk protein expression. IAk con-
structs representing the extracellular domains of  IAk-α and IAk-β chains 
were designed to include Fos and Jun sequences, respectively, and the sol-
uble IAk proteins were expressed in Baculovirus using sf9 insect cells. Af-
ter purifying the monomers on an anti-IAk column (10-2.16), the identity 
of  IAk-α and IAk-β chains was verified by Western blotting analysis using 
rabbit anti-Fos and anti-Jun polyclonal sera and peroxidase-conjugated anti-
rabbit secondary antibody, and the signals were detected by ECL. B, throm-
bin cleavage. Biotinylated IAk monomers containing CLIP 88–102 were 
digested with thrombin to release CLIP, and the proteins were resolved in 
12% SDS-PAGE analysis and stained with Coomassie blue. C, multimer-
ization of  IAk monomers. IAk proteins were biotinylated using biotin pro-
tein ligase, and the free biotin molecules were removed by dialysis in 1× 
PBS. Biotinylation was verified by mixing biotinylated proteins and SA at 
the indicated molar ratios and the multimerized complexes were resolved 
in 6% native PAGE analysis. Representative data from three individual ex-
periments are shown.
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 and anti-Jun polyclonal rabbit sera, and protein bands of  ex-
pected sizes (IAk-α, ~ 40 kDa; IAk-β, ~ 30 kDa) were obtained 
(Figure 2A). The CLIP-linked strategy required thrombin cleav-
age to facilitate the release of  the CLIP from the IAk-β chain. 
Thrombin at a concentration of  20 units/mg for 2 h at RT led 
to complete cleavage as indicated by greater migration of  IAk-β 
chain, compared with the uncleaved protein (Figure 2B). For 
initial validation, we sought to create tetramers utilizing pep-
tide precursors, which involved biotinylation and multimeriza-
tion of  IAk monomers using fluorescent dye-labeled SA. The ex-
tent of  biotinylation was confirmed by mixing biotinylated IAk 
proteins with SA; the molar ratios of  4:1 to 8:1 resulted in the 
formation of  comparable amounts of  higher molecular weight 
complexes (Figure 2C). We chose a molar ratio of  4:1 to pre-
pare tetramers for flow cytometric evaluation of  antigen-spe-
cific cells using SA-PE.
3.2. IAk tetramers bind antigen-sensitized T cells with specificity
To determine the specificity of  IAk tetramers, we used pri-
mary T cell cultures obtained from A/J mice immunized with 
Myhc-α 334–352 or RNase 43–56. We verified that the animals 
responded to the antigens based on tritiated 3[H] thymidine in-
corporation assay. Although RNase 43–56 was less immuno-
genic than Myhc-α 334–352, both peptides induced dose-de-
pendent T cell responses (Figure 3A). For tetramer staining, 
LNC were first stimulated with peptides and cultured in IL-2 
contained medium. After 5 days, viable cells were harvested and 
stained with Myhc-α 334–352 or RNase 43–56 tetramers, such 
that one of  the two tetramers served as control in its respective 
antigen-sensitized cultures; the tet+ cells were enumerated by FC. 
Myhc-α tetramers bound cells obtained from mice immunized 
with Myhc-α 334–352 (1.95%), but not from those immunized 
with RNase 43–56 (0.07%); the converse also was true of  RNase 
43–56 tetramers (RNase 43–56—0.63% and Myhc-α 334-352—
0.08%; Figure 3B). The lower frequency of  RNase tet+ cells is 
possibly due to the relatively poor response obtained in the im-
munized mice. To further verify the specificity of  IAk tetramers, 
we adopted a strategy of  enriching tet+ cells using anti-PE mag-
netic particles (Day et al., 2003; Jang et al., 2003). Expectedly, 
Myhc-α 334–352 tet+ cells were enriched antigen-specifically as 
indicated by an increase in the number of  Myhc-α 334–352 tet+ 
cells in the post-enriched fraction (4.01%) as opposed to 0.61% 
in the pre-enriched fraction with a difference of  ~ 6.6 fold be-
tween the two (Figure 3C). Such an increment was negligible 
with RNase 43–56 tetramers. Taken together, the results suggest 
that IAk tetramers specifically bind antigen-sensitized CD4 cells.
3.3. Optimized conditions for IAk tetramer staining
For routine applications of  tetramers, it was critical to opti-
mize conditions, and our goal was to enhance tetramer binding 
without compromising specificity. We considered the parameters 
of  concentration, duration, temperature, pH and the composi-
tion of  the tetramer staining medium in experiments involving 
Myhc-α 334–352-reactive cells (Figure 4). We noted that the in-
tensity of  tetramer staining was enhanced in proportion to the 
increased concentration of  tetramers (10–60 μg/ml). Such an 
enhancement was also evident when the duration for tetramer 
Figure 3. Specificity of  IAk/tetramer staining. A, proliferation response. 
A/J mice were immunized with Myhc-α 334–352 or RNase 43–56 in CFA. 
After 10 days, the mice were killed and LN from three to four mice were 
pooled and single cell suspensions were prepared. LNC were stimulated 
with the corresponding peptides for 2 days and, after pulsing with tritiated 
3[H] thymidine during the last 16 h, proliferative responses were measured 
as cpm. Mean ± SEM values from three individual experiments involving 3 
to 4 mice in each are shown. B, specificity of  IAk tetramers. LNC obtained 
from immunized mice with Myhc-α 334–352 or RNase 43–56 (control) were 
restimulated as above and the cells were maintained in IL-2 medium. Via-
ble lymphoblasts were harvested on day 9 and stained with IAk/tetramers 
and anti-CD4 and 7-AAD. After acquiring the cells by FC, tet+ cells were 
analyzed in the live (7-AAD−) CD4 subset. Representative data from three 
to five individual experiments each involving 3 to 4 mice are shown. C, en-
richment of  tet+ cells by magnetic separation. Lymphoblasts were harvested 
from cultures stimulated with Myhc-α 334–352 on day 8 poststimulation 
and stained with PE-conjugated Myhc-α 334–352 or RNase 43–56 tetra-
mers followed by anti-PE magnetic particles and the anti-PE-bound frac-
tions were enriched based on magnetic separation. The enriched fractions 
were then washed and stained with anti-CD4 and 7-AAD and after acquir-
ing the cells by FC, anti-PE-bound tet+ cells were analyzed. Data shown 
represent two individual experiments each involving 3 to 4 mice.
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binding was prolonged (0.5–3 h). Temperature had a significant 
effect on tetramer binding: staining was negligible at 4 °C when 
compared with 37 °C or RT. Although the intensity of  tetra-
mer staining was comparable at both RT and 37 °C (~ 1%), the 
background staining for RNase 43–56 tetramers was least at RT. 
Equivalent intensity of  tetramer staining (~ 1%) was obtained 
regardless of  either pH (7 to 8.2) or the amount of  FCS pres-
ent in the tetramer staining medium. Based on these results, we 
chose a concentration of  30 μg/ml of  tetramers, 3 h duration, 
RT, a medium containing 2.5% FCS and IL-2 (5 μM), and pH 
7.6 as the ideal conditions for tetramer staining.
3.4. Myhc-α 334–352 tetramers preferentially stain unactivated 
or rested cells
We and others have previously shown that MHC class II tet-
ramers have a tendency to bind activated cells, and we sought to 
verify whether IAk tetramers also share this feature (Cameron et 
al., 2001; Novak et al., 2001b; Reddy et al., 2003; Reijonen et al., 
2003). Figure 5A shows that Myhc-reactive cells expanded pro-
gressively starting on day 4 poststimulation with Myhc-α 334–
352. In a similar analysis, Myhc-α 334–352 tetramers failed to 
bind Myhc-α-reactive cells, nor was significant proliferation in 
splenocytes obtained from immunized mice (data not shown). 
We then enumerated the frequency of  Myhc-α tet+ cells in rela-
tion to the activation status of  antigen-sensitized cells. CD4 ex-
pression was upregulated in Myhc-α 334–352-reactive cells as in-
dicated by the appearance of  a CD4high population; in addition, 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Myhc-α 334–352 tetramers preferentially stained CD4high but 
not CD4low cells (4.58% vs. 0.28%; Figure 5B). We next verified 
tetramer binding in relation to CD25 expression and this was 
determined by gating CD4high and CD4low subsets. As shown 
in Figure 5C, Myhc-α 334–352 tetramers bound preferentially 
to cells expressing CD25low (3.73%) as opposed to CD25high 
cells (0.73%) within the CD4high subset and such a staining in-
tensity was low in CD4low subset ( Figure 5C). The staining of  
Myhc-α 334–352 tetramers was specific since there was negli-
gible binding to RNase 43–56 tetramers. The facts that CD25 is 
considered as an activation marker of  T cells and that Myhc-α 
Figure 4. Optimization of  reaction conditions for IAk tetramer staining. 
Myhc-α 334–352-reactive T cells were used to optimize conditions for IAk 
tetramer staining by FC involving tetramers, anti-CD4 and 7-AAD. The 
reaction conditions were concentration of  tetramers, duration of  tetramer 
staining, temperature of  staining reactions, pH and concentration of  FCS 
in the staining medium. Shown are the percentages of  tet+ cells in the live 
(7-AAD−) CD4 subset. RNase 43–56, control. Representative data from two 
individual experiments are shown.
Figure 5. IAk/Myhc-α 334–352 tetramers preferentially stain activated cells. 
A, time-course expansion of  Myhc-α-reactive cells. LNC from immunized 
mice were restimulated with Myhc-α 334–352 for 2 days and maintained 
in IL-2 medium. Viable lymphoblasts were harvested on indicated days and 
stained with tetramers, anti-CD4 or anti-CD25, and 7-AAD. Cells were ac-
quired by FC, and the percentages of  live (7-AAD−) tet+CD4+ cells were 
then determined. Tetramer analysis was also performed in relation to CD-
4lowvs. CD4high (B), or CD25lowvs. CD25high subsets gated on CD4 cells (C). 
RNase 43–56, control. Representative data from two to five individual ex-
periments with 3 to 4 mice in each are shown.
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334–352 tetramers bound predominantly to the CD25low but not 
the CD25high subset suggest that the tetramers have a preference 
to bind unactivated or rested antigen-specific T cells.
3.5. Validation of  IAk tetramers derived from CLIP-precursors
One of  the objectives of  deriving tetramers from CLIP-precur-
sors was to be able to create tetramers by loading the peptides of  
interest exogenously into the CLIP-cleaved empty IAk molecules 
(Novak et al., 2001a; Day et al., 2003; Jang et al., 2003). We op-
timized the conditions for peptide-loading in the IAk-binding as-
say, and performed peptide-exchange reactions at different molar 
ratios (from 3.3 μM:16.5 μM to 3.3 μM:132 μM) and pH (from 
5.5 to 7.5) between CLIP-cleaved, IAk molecules and Myhc-α 
334–352. Based on preliminary experiments, 3.3 μM:66.6 μM 
was an optimal ratio, and, combined with a pH range of  6.0–7.5, 
resulted in comparable peptide loading (Figure 6A). We then 
created tetramers by loading Myhc-α 334–352 or RNase 43–56 
into biotinylated CLIP-cleaved IAk molecules followed by mul-
timerization using SA-PE, and the reagents were used to stain 
Myhc-α 334–352-reactive cells by FC. As shown in Figure 6B, 
Myhc-α 334–352 tetramers generated under all the pH condi-
tions stained myosin-reactive cells with specificity, but the tetra-
mers prepared at pH 7.0 resulted in maximum staining intensity 
(0.8%). The data prove that the CLIP precursors could be used 
to create IAk tetramers to detect antigen-specific cells.
3.6. Binding of  Myhc-α 334–352 tetramers do not correlate with 
CD40L expression
It has been previously shown that CD40L can be used as a 
marker of  activated antigen-specific cells (Chattopadhyay et al., 
2005; Frentsch et al., 2005). We tested whether Myhc-α 334–
352 tetramers preferentially bind Myhc-α-specific cells express-
ing CD40L. We noted that CD40L-expressing cells were evident 
3 days after stimulation with Myhc-α 334–352, the expression 
of  which progressively increased, reaching a peak on day 6 fol-
lowed by a decline (Figure 7A). But the tetramer analysis re-
vealed that only a fraction of  these cells bound Myhc-α tetra-
mers (tet+CD40L−, 0.67% vs. tet+CD40L+, 0.13%) ( Figure 7B). 
Similar results were obtained when tetramer analysis was per-
formed in relation to endogenous expression of  CD40L based 
on intracellular staining (data not shown). We also investigated 
whether blocking CD40–CD40L interaction with CD40 block-
ing antibody (clone, IC10, eBioscience; Zhang et al., 2007; Baker 
et al., 2008; Otani et al., 2011) during antigenic stimulation can 
facilitate stabilization of  CD40L such that tet+ cells can then be 
Figure 6. Specificity of  IAk/Myhc-α 334–352 tetramers created based on peptide-exchange reaction. A, peptide-exchange reaction. The CLIP-cleaved 
IAk monomers were loaded with Myhc-α 334–352 at 3.3 μM:66.6 μM ratio in peptide-exchange buffer, pH 5.5 to 7.5, overnight at RT. After blocking, bi-
otinylated anti-DNP was added followed by europium-labeled SA in DELFIA buffer and DELFIA-enhancer, and fluorescence counts were measured. 
Mean ± SEM values representing two individual experiments are shown. B, tetramer staining. The CLIP-cleaved biotinylated IAk monomers were loaded 
with Myhc-α 334–352 or RNase 43–56 as above. Tetrameric complexes were then obtained by mixing peptide-loaded IAk monomers with PE-conjugated 
SA at 4:1 molar ratio and used to stain Myhc-α-reactive cells by FC. Percentages of  tet+ cells were then enumerated in the live CD4 subset (left panel). 
Mean ± SEM values are shown (n = 3). The right panel shows the dot plot representation of  tetramer staining.
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better correlated with CD40L-expression. This was not the case 
as there were no significant differences in the expression levels 
of  CD40L in anti-CD40-treated vs. -untreated cells. Likewise, 
treatment with CD40 blocking antibody did not improve tetra-
mer binding (data not shown). Taken together, our data suggest 
that binding of  Myhc-α 334–352 tetramers does not correlate 
with CD40L expression in antigen-stimulated cells.
3.7. Enumeration of  the frequency of  Myhc-α 334–352-reactive 
cells ex vivo
MHC class II tetramers are useful tools to analyze antigen-
specific CD4 cells at a single cell level, but their tendency to stain 
activated cells limits the use of  these reagents ex vivo. We previ-
ously had shown that the binding ability of  IAs tetramers can 
be enhanced by treating the cells with NASE prior to tetramer 
staining, and we adopted this method to detect myosin-specific 
cells ex vivo ( Reddy et al., 2003). First, Myhc-α-reactive T cells 
were generated from immunized mice and the cells were rested 
for 2 weeks in IL-2 medium. Viable cells were then treated with 
or without NASE prior to tetramer staining and the tet+ cells 
were enumerated by FC. As shown in Figure 8A, NASE treat-
ment enhanced the detection of  Myhc-α-specific cells by approx-
imately 4.5 fold (3.2% vs. 0.68%). We used these conditions to 
detect Myhc-α-reactive cells in the LNC obtained from immu-
nized mice ex vivo. We noted that NASE activated the cells non-
specifically independent of  antigen-stimulation as indicated by 
the appearance of  a distinct population composed of  large gran-
ular cells in which CD69, CD62L, CD44 and, to a lesser degree, 
CD25 were upregulated ( Figure 8B). Corresponding to these 
markers, we evaluated tetramer staining in cells treated with or 
without NASE and we found that CD25 was better suited to enu-
merate antigen-sensitized CD4 cells. Since we could not clearly 
differentiate CD25low and CD25high subsets, tet+ cells were enu-
merated by gating the whole CD25 population. Figure 8C shows 
that the detection of  Myhc-α 334–352 tet+ cells increased ap-
proximately two-fold with NASE treatment (0.28% vs. 0.13%). 
A similar trend was also noted with RNase tetramers, but to a 
lesser degree (0.07% vs. 0.12%), and this level of  background 
staining persisted consistently. Nonetheless, as predicted, the en-
hanced sensitivity obtained with NASE treatment allowed us to 
detect more Myhc-α-sensitized cells in immunized mice. Addi-
tionally, we also examined Myhc-α 334–352 tet+ cells in mice 
that received CFA alone but the reactivity was low (~ 0.07%). 
To further prove the specificity of  Myhc-α 334–352 tetramers, 
we enriched tet+ cells corresponding to Myhc-α 334–352 and 
RNase 43–56 tetramers using anti-PE magnetic particles ( Fig-
ure 9). Expectedly, the enriched fraction contained 0.92% of  
Myhc-α 334–352-reactive cells as compared with 0.21% prior to 
enrichment with a difference of  ~ 4 fold and reactivity to RNase 
43–56 tetramers was minimal proving that IAk tetramers can be 
used to enumerate the frequencies of  antigen-specific cells ex vivo.
4. Discussion
We have described the generation of  IAk tetramers that al-
lowed us to detect cardiac myosin-specific CD4 cells in mice bear-
ing the H-2 allele, IAk. Traditionally, limiting dilution analysis 
and cytokine ELISPOT assay have been used to enumerate the 
frequencies of  antigen-specific cells, but low specificity and the 
tedious nature of  these assays limit their use for routine appli-
cations (Buckner et al., 2002; Mallone and Nepom, 2004; Car-
neiro et al., 2009). In contrast, the use of  tetramers permits easy 
and rapid detection including the phenotypic characterization 
of  antigen-sensitized cells at a single cell level by FC (Altman 
et al., 1996; Massilamany et al., 2010).
Unlike class I tetramers, the creation of  class II tetramers is 
technically challenging and it requires stable expression of  sol-
uble monomers composed of  MHC II-α and β chains. Class II 
tetramers were originally created by tethering peptide sequences 
covalently to the N-terminus of  the class II-β chain, but this ap-
proach requires generation of  tetramers for each peptide indi-
vidually (Kozono et al., 1994; Altman et al., 1996). The newer 
approach involves expression of  empty class II molecules into 
which peptides are loaded exogenously, thereby facilitating cre-
ation of  tetramers utilizing a single recombinant virus (Novak 
et al., 2001a; Kwok et al., 2002, Day et al., 2003; Jang et al., 
2003). Some empty class II molecules (e.g., DQ8) tend to aggre-
gate, requiring protection of  the peptide-binding site ( Jang et 
al., 2003), but the derivation of  tetramers from CLIP precursors 
overcomes this disadvantage. Additionally, exogenous loading 
allows peptides to bind MHC molecules in different registries 
( Novak et al., 2001a; Day et al., 2003; Jang et al., 2003). We 
adopted both peptide- and CLIP-tethered approaches to gener-
ate IAk tetramers, validating the reagents with Myhc-α-reactive 
cells obtained from mice immunized with Myhc-α 334–352 us-
ing RNase 43–56 tetramers as controls.
First, we validated IAk tetramers derived from peptide pre-
cursors. By using two tetramers (Myhc and RNase) and two cell 
Figure 7. IAk/Myhc-α 334–352 tetramers stain only a fraction of  CD40L-
expressing cells. A, time-course expansion of  CD40L-expressing CD4 cells. 
LNC harvested from immunized mice were restimulated with Myhc-α 334–
352 for 2 days and rested in IL-2 medium, and CD40L-expressing cells were 
determined in the live CD4+ subset by FC. B, tetramer analysis. Cells were 
harvested on day 8 poststimulation, stained with anti-CD40L followed by 
tetramers, anti-CD4 and 7-AAD and acquired by FC. Percentages of  tet+ 
cells were then analyzed in relation to CD40L expression within the live (7-
AAD−) CD4 subset. Representative data from three experiments are shown.
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types that react specifically to Myhc-α 334–352 or RNase 43–
56, we demonstrated that IAk tetramers bind to antigen-sensi-
tized cells with specificity. The conditions optimized for tetra-
mer staining include concentration (30 μg/ml), duration (3 h), 
temperature (RT), pH (7.6) and the amount of  FCS in the stain-
ing medium (2.5%). We and others had previously reported sim-
ilar conditions for IAs, IAg7, IAu and IAb tetramers, suggesting 
that the tetramer reaction conditions for various IA alleles are 
generally similar (Liu et al., 2000; Radu et al., 2000; Reddy et 
al., 2003; Korn et al., 2007). We noted that the staining inten-
sity increased proportionally with the increased concentration 
of  tetramers, but the concentration of  30 μg/ml was chosen to 
conserve the reagent. Likewise, the specificity of  Myhc-α 334–
352 tetramers was not affected by the presence or absence of  
FCS in the staining medium, but this component was included 
to keep the cells healthy in the staining reactions. Second, to 
enhance versatility, we sought to create tetramers utilizing IAk/
CLIP precursors, which permitted generation of  Myhc-α 334–
352 or RNase 43–56 tetramers by loading the peptides into CLIP-
cleaved empty IAk monomers. As previously shown (Harding 
et al., 1991; Sette et al., 1992), we found that a pH range of  6.0 
to 7.5 facilitated peptide loading into IAk molecules. Myhc-α 
tetramers derived from these IAk/peptide complexes stained 
Myhc-α-reactive cells with specificity, proving that the CLIP 
precursors can be used to create tetramers easily, thus broaden-
ing the applications of  IAk tetramers. However, it is to be noted 
that the staining intensity obtained with the tetramers derived 
from CLIP precursors was generally less than that observed with 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8. Enumeration of  the frequency of  Myhc-α 334–352-specific CD4 cells ex vivo. A, effect of  NASE on tetramer binding. LNC from immunized mice 
were restimulated with Myhc-α 334–352 for 2 days followed by resting in IL-2 medium for 2 weeks. Cells were treated with or without NASE, followed 
by staining with tetramers, anti-CD4 and 7-AAD. After acquiring the cells by FC, tet+ cells were enumerated in the live (7-AAD−) CD4 subset. Data repre-
sents one of  the three individual experiments. B, effect of  NASE on T cells. A/J mice were immunized twice with Myhc-α 334–352 in CFA with an inter-
val of  1 week. After 7 days, mice were killed and LN were harvested, and single cell suspensions were prepared. LNC were treated with or without NASE, 
stained with indicated markers, anti-CD4 and 7-AAD and acquired by FC. Percentages of  each marker were analyzed in CD4 subset gated on ‘G1 and 
G2’ (n = 3). C, tetramer analysis ex vivo. LNC were obtained from mice immunized with Myhc-α 334–352 and CD4 cells were isolated by magnetic separa-
tion. After treating the cells with or without NASE, cells were stained with tetramers, anti-CD4, anti-CD25 and 7-AAD, and percentages of  tet+ cells were 
analyzed in the live (7-AAD−) CD25-expressing CD4 subset by FC. Data representing 3 individual experiments involving 3 to 5 mice in each are shown.
Figure 9. Enrichment of  tet+ cells ex vivo by magnetic separation. CD4 
cells were enriched from mice immunized with Myhc-α 334–352 on day 
14 postimmunization by negative selection based on magnetic separation. 
Cells were then treated with NASE followed by staining with PE-conjugated 
IAk tetramers and anti-PE magnetic particles. After enrichment, cells were 
washed and stained with anti-CD4 and 7-AAD and acquired by FC and the 
anti-PE-bound tet+ cells were then analyzed. Representative data from two 
individual experiments involving a pool of  3 to 5 mice in each are shown.
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peptide-tethered tetramers. This may be due to the possibility 
that some of  the IAk molecules in tetramers made from CLIP 
precursors might not have been loaded with the peptides as op-
posed to peptide-tethered tetramers in which every IAk mole-
cule is embedded with a peptide.
In our previous experience with IAs tetramers, which were 
created to detect PLP 139–151-specific CD4 cells in SJL mice, 
we had noted that tetramer binding peaked between days 4 and 
6 poststimulation with PLP 139–151, but the staining became 
negligible by day 10 (Reddy et al., 2003). In contrast, convinc-
ing evidence of  staining occurred with Myhc-α tetramers in 
LNC stimulated with Myhc-α 334–352 for at least 4 days after 
preparation. The staining increased progressively but persisted 
even up to day 10. This observation is critical to note because 
we generally use antigen-stimulated cells within 4 days after 
activation for adoptive transfer experiments, and our data indi-
cated that antigen-specific T cell expansion occurs rather slowly 
in A/J mice. Whether such a slow expansion is a characteristic 
of  particular immunogens or mouse strains remains to be deter-
mined. Importantly, under similar conditions, we failed to ob-
tain Myhc-α 334–352-responsive T cell cultures from splenocytes 
harvested from immunized mice. Although it is expected that 
antigen-sensitized T cells are more concentrated in draining LN 
than in spleens, the lack of  T cell responses in the latter implies 
that the use of  splenocytes is not a viable option to determine 
antigen-specific T cell reactivity, at least for Myhc-α 334–352. 
Our data suggest that the antigen-stimulated LNC but not sple-
nocyte cultures maintained in IL-2 medium for approximately 
8–10 days are better suited for functional studies in A/J mice.
We and others had previously shown that class II tetramers 
have a greater tendency to bind activated cells (Cameron et al., 
2001; Novak et al., 2001b; Reddy et al., 2003; Reijonen et al., 
2003). Contrary to our expectations, we noted that Myhc-α tetra-
mers showed a preference for rested or unactivated cells express-
ing low levels of  CD25. Conceivably, because tetramer binding 
requires high-affinity T cell receptor (TCR) interactions, cells 
bearing low-affinity TCRs may fail to be detected by tetramers 
(Mallet-Designe et al., 2003; Reddy et al., 2003; Vollers and 
Stern, 2008). The lack of  significant binding to the CD25high 
subset suggests that the affinity of  TCRs of  Myhc-α-reactive 
cells may differ between CD25lowtet+ and CD25hightet+ popula-
tions. Alternatively, the differential binding of  tetramers to CD-
25low and CD25high subsets might be due to differences in TCR 
clustering/densities or their organization in the respective pop-
ulations. For example, TCR clustering was inversely correlated 
with CD25 expression in the transgenic T cells bearing high-af-
finity TCRs specific to myelin basic proteins 1–9 (Pastor et al., 
2006). Likewise, in the CD8 T cell system involving hemagglu-
tinin 533–541-specific TCRs, transient loss of  tetramer binding 
was noted in relation to increased expression of  CD25 shortly 
after antigen stimulation, and this phenomenon was ascribed 
to change in the display or organization of  TCRs (Drake et al., 
2005). Previously, it was shown that CD40L expression can be 
used as a marker of  antigen-specific cells (Chattopadhyay et al., 
2005; Frentsch et al., 2005); we therefore expected that binding 
of  Myhc-α tetramers would correlate with CD40L expression, 
but this was not the case. This discrepancy could be due to the 
fact that we performed tetramer analysis in relation to CD40L-
expression on day 8 poststimulation with Myhc-α 334–352, the 
time point at which tetramer staining intensity reached its peak 
(Figure 5A), as opposed to 6 h at which CD40L expression was 
examined previously (Frentsch et al., 2005). It should be noted 
that Myhc-α tetramers cannot be used to stain cells immediately 
after antigen stimulation for at least 4 days because of  their in-
ability to bind antigen-reactive cells with specificity. Therefore, 
lack of  correlation between tetramer binding and CD40L ex-
pression does not mean that CD40L-expressing cells are not 
antigen-specific. Alternatively, the class II tetramers may be in-
herently limited in binding only to high-affinity TCR-bearing 
cells, and the appearance of  tet+CD40L+ and tet+CD40L− sub-
sets may represent antigen-reactive cells containing high- and 
low-affinity TCRs, respectively.
One objective of  deriving tetramers is the ability to enumer-
ate the frequency of  antigen-specific cells ex vivo, obviating the 
need to stimulate the cells in vitro. Accumulated literature sug-
gests that class II tetramers bind activated cells, but not resting 
cells, even though they are antigen-specific ( Cameron et al., 
2001; Novak et al., 2001b; Reddy et al., 2003; Reijonen et al., 
2003). This makes it difficult to accurately determine the fre-
quencies of  antigen-specific T cell repertoires. To overcome this 
limitation, we adopted a strategy of  exposing the cells to NASE 
prior to tetramer staining ( Daniels et al., 2001; Reddy et al., 
2003), which facilitated detection of  approximately two-fold 
more with Myhc-α tet+ cells than those detected without NASE 
in mice immunized with Myhc-α 334–352. The enhanced bind-
ing of  Myhc-α tetramers obtained with NASE treatment may 
be due to two mechanisms: 1) NASE may enhance adhesive-
ness between TCR and tetramers by removing sialic acid from 
the cell surface, thereby reducing the net charge ( Krieger et al., 
1988; Daniels et al., 2001), or 2) NASE can nonspecifically ac-
tivate T cells ( Krieger et al., 1988; Reddy et al., 2003). Since 
activated cells generally can be bound better by class II tetra-
mers, we activated LNC obtained from immunized mice tran-
siently for 6–12 h with various polyclonal activators (such as 
CD3, TCR and CD28 antibodies, phorbol 12-myristate 13-ac-
etate/ionomycin, and superantigens), but none of  these agents 
enhanced either the sensitivity or specificity of  Myhc-α-reactive 
cells (data not shown). Although low, background staining with 
RNase tetramers was consistently noted in ex vivo staining reac-
tions. We chose the bovine sequence for RNase 43–56 as a con-
trol, and the bovine sequence is 92% similar to mouse RNase, 
except that serine at position 50 in bovine RNase is substituted 
with proline in the mouse. It has been shown that the naïve pe-
ripheral repertoires contain autoreactive T cells for various self-
antigens ( Klein and Kyewski, 2000; Romagnani, 2006; Root-
Bernstein, 2007). Whether RNase tet+ cells represent such a pool 
is not known, and we did not pursue this aspect in our studies.
In summary, we have demonstrated that IAk/Myhc-α tetra-
mers facilitate the detection of  Myhc-α 334–352-reactive CD4 
cells with specificity. The tetramers are helpful tools to charac-
terize the appearance, disappearance and persistence of  cardiac 
myosin-reactive CD4 T cell repertoires in mice bearing the H-2/
IAk allele. These include A/J, B10.A, B10.BR and CBA/J mice, 
which show varying degrees of  autoimmune responses to car-
diac myosin (Neu et al., 1987b; Smith and Allen, 1991; Don-
ermeyer et al., 1995). For example, A/J, CBA/J and B10.BR 
mice are highly susceptible to EAM and Coxsackievirus B3-in-
duced myocarditis, whereas B10.A mice are relatively resistant 
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(Wolfgram et al., 1986; Neu et al., 1987a; Neu et al., 1987b; 
Leslie et al., 1990; Gauntt et al., 1995). Our data obtained with 
the EAM protocol suggest that myosin-specific CD4 cells can 
be reliably enumerated in LNC but not in splenocytes, and that 
NASE treatment prior to tetramer staining facilitates detection 
of  antigen-specific cells ex vivo. From the practical stand point, 
IAk tetramers could serve as useful tools to enumerate the pre-
cursor frequencies of  antigen-specific cells in cultures expanded 
in vitro since activation facilitates efficient binding of  IAk tetra-
mers. Because of  this limitation, it is difficult to accurately an-
alyze the frequencies of  Myhc-α 334–352-specific cells ex vivo.
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